Al Nahdi Medical Company SCJSC
SAU:4164
Intrinsic Value
Nahdi Medical Co. operates pharmacy stores. [ Read More ]
The intrinsic value of one
Al Nahdi Medical Company SCJSC
stock under the Base Case scenario is
122.89
SAR.
Compared to the current market price of 137.4 SAR,
Al Nahdi Medical Company SCJSC
is
Overvalued by 11%.
Al Nahdi Medical Company SCJSC's market price has consistently been higher than its intrinsic value.This persistent overvaluation suggests the market may be overly optimistic about
Al Nahdi Medical Company SCJSC or that its price is influenced by factors unrelated to fundamentals.
Al Nahdi Medical Company SCJSC's market capitalization is 17.9B SAR.
Al Nahdi Medical Company SCJSC stock price is 137.4 SAR.
Al Nahdi Medical Company SCJSC stock (122.89 SAR) is 11% less than its price (137.4 SAR).
Al Nahdi Medical Company SCJSC stock (80.31 SAR) is 42% less than its price (137.4 SAR). Open DCF Valuation
Al Nahdi Medical Company SCJSC stock price (137.4 SAR) is 17% less than its Relative Value (165.46 SAR). Open Relative Valuation
Al Nahdi Medical Company SCJSC has upside potential of 19% compared to the average analyst price target.
Open Wall St Estimates
Al Nahdi Medical Company SCJSC has positive Net Income for the last twelve months.
Al Nahdi Medical Company SCJSC's Revenue has grown by 1% over the past 12 months.
Al Nahdi Medical Company SCJSC has positive Operating Income for the last twelve months.
Al Nahdi Medical Company SCJSC's Revenue is forecast to grow at a rate of 6% per year over the next 3 years.
Al Nahdi Medical Company SCJSC has negative Net Debt. This means that the company has more cash and short-term investments (910m SAR) than debt (871m SAR).
Al Nahdi Medical Company SCJSC's ROIC (Return on Invested Capital) for the past 12 months is very high and is equal to 27%.
Al Nahdi Medical Company SCJSC's short-term assets (3B SAR) exceed its short-term liabilties (2B SAR).
Al Nahdi Medical Company SCJSC's long-term assets (5B SAR) exceed its long-term liabilties (3B SAR).
Al Nahdi Medical Company SCJSC's ROE (Return on Equity) for the past 12 months is very high and is equal to 38%.
Al Nahdi Medical Company SCJSC has positive Gross Profit for the last twelve months.
Al Nahdi Medical Company SCJSC has positive Free Cash Flow for the last twelve months.
Al Nahdi Medical Company SCJSC has very high three-year average ROIC (Return on Invested Capital): 27%. The company is very efficient at using invested capital to generate operating income.
Al Nahdi Medical Company SCJSC's D/E (Debt to Equity) is very low and is equal to 0.35.
Al Nahdi Medical Company SCJSC has very high three-year average ROE (Return on Equity): 45%. The company is very efficient at transforming stockholders' equity into net income.
Al Nahdi Medical Company SCJSC's Altman Z-Score is very high and is equal to 6.24.
Valuation Backtest
Al Nahdi Medical Company SCJSC
Run backtest to discover the historical profit from buying and selling
Al Nahdi Medical Company SCJSC
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Al Nahdi Medical Company SCJSC
Balance Sheet Decomposition
Al Nahdi Medical Company SCJSC
| Current Assets | 2.8B |
| Cash & Short-Term Investments | 909.7m |
| Receivables | 172.8m |
| Other Current Assets | 1.7B |
| Non-Current Assets | 2.6B |
| Long-Term Investments | 254.3m |
| PP&E | 2.3B |
| Intangibles | 51.2m |
| Current Liabilities | 1.6B |
| Accounts Payable | 894.3m |
| Accrued Liabilities | 320.1m |
| Other Current Liabilities | 416.7m |
| Non-Current Liabilities | 1.3B |
| Long-Term Debt | 870.6m |
| Other Non-Current Liabilities | 406.9m |
Earnings Waterfall
Al Nahdi Medical Company SCJSC
|
Revenue
|
8.7B
SAR
|
|
Cost of Revenue
|
-5.2B
SAR
|
|
Gross Profit
|
3.5B
SAR
|
|
Operating Expenses
|
-2.6B
SAR
|
|
Operating Income
|
960.7m
SAR
|
|
Other Expenses
|
-68.1m
SAR
|
|
Net Income
|
892.6m
SAR
|
Free Cash Flow Analysis
Al Nahdi Medical Company SCJSC
Profitability Score
Profitability Due Diligence
Al Nahdi Medical Company SCJSC's profitability score is 67/100. The higher the profitability score, the more profitable the company is.
Score
Al Nahdi Medical Company SCJSC's profitability score is 67/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Al Nahdi Medical Company SCJSC's solvency score is 69/100. The higher the solvency score, the more solvent the company is.
Score
Al Nahdi Medical Company SCJSC's solvency score is 69/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Al Nahdi Medical Company SCJSC
According to Wall Street analysts, the average 1-year price target for
Al Nahdi Medical Company SCJSC
is 162.87 SAR
with a low forecast of 141.4 SAR and a high forecast of 184.8 SAR.
Shareholder Return
Price
Al Nahdi Medical Company SCJSC
| Average Annual Return | 9.7% |
| Standard Deviation of Annual Returns |
N/A
|
| Max Drawdown | -35% |
| Market Capitalization | 17.9B SAR |
| Shares Outstanding | 130 343 400 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Al Nahdi Medical Company SCJSC
Country
Industry
Market Cap
Dividend Yield
Description
Nahdi Medical Co. operates pharmacy stores. The company is headquartered in Jeddah, Makkah. The company went IPO on 2022-03-22. The firm is engaged in the wholesale and retail trading of cosmetics, pharmaceutical products, special and healthy foods and medical equipment. The firm operates two operating segments: Front Shop and Pharma. The firm provides medicine, wellness, mom & baby, beauty and other wide-ranging FMCG products. The firm provides omni-health services through its polyclinics, express clinics, telemedicine, labs, and home healthcare. The firm operates approximately 1,150 stores in 144 cities and towns in the Kingdom of Saudi Arabia and the United Arab Emirates. The Company’s subsidiaries include Al Nahdi Care, Sakhaa Golden Company, and Nahdi Investment Company.
Contact
IPO
Employees
Officers
The intrinsic value of one
Al Nahdi Medical Company SCJSC
stock under the Base Case scenario is
122.89
SAR.
Compared to the current market price of 137.4 SAR,
Al Nahdi Medical Company SCJSC
is
Overvalued by 11%.
You don't have any saved screeners yet
